Navigation Links
ARVO Foundation for Eye Research honors Deisseroth with first Ludwig von Sallman Clinician-scientist Award
Date:3/29/2011

Rockville, MD Karl Deisseroth, MD, PhD, has been named the first recipient of the Ludwig von Sallman Clinician-scientist Award, presented by the ARVO Foundation for Eye Research (AFER) to a clinician-scientist under age 40.

Deisseroth, associate professor of Bioengineering and Psychiatry at Stanford University, is being recognized for his ground breaking work in developing and using optogenetic approaches to study neuronal function.

"It is an honor to recognize the far-reaching impact Dr. Deisseroth's technique has had on ophthalmology and vision science, said Gary W. Abrams, MD, FARVO, chair, AFER Board of Governors. "We have great expectations that his pioneering work will lead to real advances in understanding basic retinal function and the restoration of vision in the future."

The optogenetic technique is an experimental approach based on the insertion of opsins light sensitive molecules in photoreceptors as well as many other organisms, including plants and algae into cells, allowing for fine control of the cell upon flashing light. The novel approach is being used by scientists around the world to probe how the brain works and is gaining acceptance by the science community as critical to the development of other major biological techniques, including PCR and patch-clamp electrophysiology.

A published author of more than 70 papers, Deisseroth has been widely recognized with honors and awards during his career. He earned his bachelor's degree from Harvard University in 1992 and received his PhD in 1998 and MD in 2000 from Stanford.

Deisseroth will present a lecture at a minisymposium, "Optogenetics, Visual Function and Restoration," during the 2011 Association of Research in Vision and Ophthalmology Annual Meeting, Monday, May 2 at the Greater Fort Lauderdale/Broward County Convention Center.


'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Page: 1

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. Entertainment Software Association Foundation awards grant to FAS for immune attack
3. National Science Foundation grants Clemson professors award to develop nanoprobes
4. Dunn Foundation gives Rice $3M for collaborative research grants
5. National Science Foundation grant expands UMCES oyster research
6. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
7. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
8. Parkinsons Disease Foundation announces award of $150,000
9. Meyskens honored with AACR-Prevent Cancer Foundation award
10. The MDS foundation supports vidazas recommendation for European approval
11. Boost from McGill, Gates Foundation helps Africans control pharma research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/19/2017)... , Jan. 19, 2017 Sensory ... experience and security for consumer electronics, and ... processing systems and cybersecurity solutions, today announced a ... and financial institutions worldwide to bolster security of ... end-to-end secure user authentication platforms they offer, innerCore ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... discovery and development of precision treatments for neurodegenerative diseases, today announced it has ... the ProMIS approach.” This is one of a series of commentaries from ProMIS’s ...
(Date:2/22/2017)... Aethlon Medical, Inc. (Nasdaq: AEMD ... validated the ability of the Aethlon Hemopurifier® to capture ... in immune-suppressed sepsis patients and also contribute to organ ... of the study was to validate the in ... and Herpes Simplex virus 1 (HSV1) by the Hemopurifier®. ...
(Date:2/21/2017)... 2017 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... to protect and restore the health of patients, intends to report ... 2016 on Thursday, March 2, 2017, and to host a conference ... for the call is as follows: U.S. (toll free): ... ...
(Date:2/21/2017)... ... February 21, 2017 , ... Cancer diagnostics workflow solution ... its executive team to lead the development and commercialization of its Cancer Information ... the diagnosis and treatment of cancer. The CIDT addresses the need for curated ...
Breaking Biology Technology: